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Introduction
Biocompatibility and tissue-matching of implanted bioma-
terials is a major consideration in tissue engineering, par-
ticularly when translation from the lab to the clinic is the 
primary aim. An important component of biocompatibility 
is stiffness, which is of particular concern in the central 
nervous system (CNS) due to its relatively soft nature.1 
Increased inflammatory and immunological responses 
have been reported after implant of stiff materials in the 
CNS, for example, in a direct comparison of soft (100 Pa) 
compared to stiff (30 kPa) polyacrylamide gel implanta-
tion into rat brain,2 and after electrode implant on the spi-
nal cord.3 Reduced host inflammatory cell numbers are 
seen in rodent studies where hydrogels of similar stiffness 
to spinal cord injury (SCI) are transplanted.4,5
Hydrogel implantation offers multiple benefits for SCI 
therapy. Hydrogels form a substitute extracellular matrix 
and porous structure which modifies the injury environment 
promoting cellular and axon infiltration.6,7 Hydrogels can be 
used as a vehicle for molecular,8 drug9 or cell-based10,11 
‘combinatorial’ therapies (for reviews see12–15). These can 
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have synergistic effects, for example, lack of cell survival 
and integration is one of the main barriers to developing a 
clinically effective cell-based treatment for SCI.16 
Encapsulation of cells within a hydrogel has been demon-
strated to increase cell survival after CNS transplant in 
rodent models.10,17,18 Injectable materials can mould to the 
injury lesion before polymerisation in situ15 allowing mini-
mally invasive delivery. The adaptation of minimally immu-
nogenic and previously US Food and Drug Administration 
(FDA)-approved materials for encapsulated cell delivery 
could further accelerate clinical hydrogel use.19
Despite these valuable benefits and advances, a robust 
approach to stiffness matching of hydrogels to the spinal 
cord on clinics has not been developed. Indeed, there is 
limited information available for spinal cord applications, 
particularly in vivo stiffness values; the stiffness of in vivo 
injured spinal cord is unknown. This knowledge gap repre-
sents a major obstacle to safe implantation of hydrogels on 
clinics. The majority of previous studies on spinal cord 
stiffness have been conducted ex vivo and post-mortem, 
and existing in vivo studies have used mechanical tensile 
measures20–23 which require manipulation and dissection 
of the cord that would clearly be inappropriate for clinical 
patients. This precludes matching of a hydrogel implant to 
a patient’s specific injury, required for development of per-
sonalised therapies.
We therefore aimed to establish a clinical method to 
determine the stiffness of injured spinal cord, and to use 
this as a tool to match hydrogel stiffness. Ultrasound elas-
tography (USE) is a non-invasive method of determining 
the stiffness of a tissue. It has been successfully used in 
people for ancillary diagnosis of mammary neoplasia24 and 
staging of liver fibrosis,25 and has been applied to the spinal 
cord of experimental dogs where large areas of the spinal 
cord were exposed.26 Acoustic radiation force impulse USE 
detects the speed of displacement of target tissue (shear 
wave velocity) in response to an acoustic impulse gener-
ated from the ultrasound transducer. This speed varies with 
the stiffness of the tissue27 and can be mathematically con-
verted to modulus of elasticity28,29 allowing quantitative 
comparisons; materials with a higher elastic modulus will 
be stiffer and deform less for a given stress. The technique 
is relatively straightforward to perform, and we hypothe-
sised could provide a readily clinically available method to 
obtain measures of the stiffness of spinal cord in the clinic.
To test this hypothesis, we used the clinical canine 
translational model of SCI,30–32 companion dogs with 
spontaneous SCI presenting to referral veterinary hospi-
tals. These animals represent a well-established large ani-
mal model of SCI30–33 with heterogeneous and mixed 
compressive-contusive lesions similar to those seen in 
humans.34 The model provides an important means of 
screening experimental interventions for feasibility and 
efficacy in a clinical setting.33,35 Testing intraoperative spi-
nal cord USE within a referral veterinary hospital presents 
similar challenges and logistical constraints to those faced 
in a human hospital in terms of available time and access, 
safety, sterility, and operation of ultrasound equipment.
Having obtained USE data for in vivo injured and nor-
mal spinal cord, we applied the same USE technique to 
collagen hydrogels to investigate matching of a biomate-
rial implant to clinically determined SCI stiffness. Collagen 
hydrogels were tested with or without encapsulation of 
canine olfactory ensheathing cells (OECs). OECs repre-
sent an important, clinically relevant cell transplant popu-
lation for SCI. They have been shown to improve walking 
(BBB score) in two recent meta-analyses of rodent experi-
ments,36,37 have shown efficacy in a clinical trial using the 
canine model33 and have undergone phase 1 human trials 
demonstrating safety.38 OECs have high viability encapsu-
lated in collagen,39 supporting the use of collagen as a pro-
tective delivery vehicle for OEC transplant.
Our aims were therefore to (1) test the feasibility of 
intraoperative spinal cord USE during therapeutic surgery, 
(2) generate stiffness measures for large animal natural 
SCI providing a ‘target’ stiffness for hydrogel synthesis, 
and (3) establish comparative USE measures of collagen 
hydrogel stiffness with encapsulation of a clinically rele-
vant cell population (OECs).
Methods
Canine OEC culture
Canine mucosal OECs used in these experiments were 
obtained from cells preserved during a previous canine clin-
ical trial,33 and cultured as previously described.33,40,41 
Briefly, cells were cultured on poly-L-lysine (Sigma) coated 
flasks in media consisting of low glucose Dulbecco’s 
Modified Eagle’s Media (Sigma), 10% foetal bovine serum 
(Gibco), and 1% penicillin and streptomycin (Sigma) with 
added growth factors: 20 ng/mL neuregulin-1 (R&D 
Systems) and 2µM forskolin (Sigma). Media was replaced 
every 3–4 days until cell confluence was observed then pas-
saged into further flasks or split according to cell count by 
haemocytometer for encapsulation in collagen hydrogel as 
detailed below. Purified OEC cultures were obtained using 
the differential attachment strengths of OECs and fibro-
blasts as previously reported.33,42
Collagen hydrogel synthesis and OEC 
encapsulation
Collagen hydrogels were synthesised as previously 
described.43 Briefly, type 1 rat tail collagen (Corning High 
Concentration, Scientific Laboratory Supplies Ltd), was 
diluted in 0.02M acetic acid to a range of concentrations; 4.5, 
6.0, 7.5 mg/mL. 10x minimum essential media α (Gibco, 
with nucleosides) was added followed by neutralisation with 
1M sodium hydroxide. All reagents were kept on ice. After 
neutralisation, 500 µL of hydrogel was transferred to 48-well 
plates and incubated for 20 min at 37°C in 5% CO2.
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Encapsulation of OECs was achieved by directly re-
suspending a cell pellet (obtained after centrifuging cells 
in solution at 1000 r/min for 5 min) with the neutralised 
liquid collagen mixture prior to incubation as above. OECs 
were encapsulated at a concentration of 1.25 million cells 
per 100 µL hydrogel (equivalent to previous canine trans-
plants33). Once gelled after 20-min incubation, hydrogels 
were removed from the 48-well plates, submerged in cell 
culture medium (as defined above) in 24-well plates and 
maintained at 37°C in 5% CO2.
Immunocytochemical procedures
Cells for immunocytochemistry were prepared on poly-L-
lysine coated glass coverslips and fixed with 4% paraform-
aldehyde for 10 min at room temperature. Fixed cells were 
washed with 0.3% Triton in phosphate buffered saline 
(PBS), blocked for 1 h in 10% normal goat serum (Vector 
Laboratories) then incubated with primary antibody over-
night at 4°C: mouse anti-nerve growth factor receptor 
(p75) (MAB5364, Millipore) at 1:200 to label OECs and 
rabbit anti-fibronectin (AO245, DAKO) at 1:400 to stain 
for fibroblast contaminants in the primary OEC cultures. 
Complementary secondary antibodies (anti-mouse 546 
(Abcam) and anti-rabbit 660 (Abcam)) were applied at 
1:500 dilution for 2 h at room temperature and coverslips 
mounted using hard-set mounting media with 4′,6-diamid-
ino-2-phenylindole (DAPI) (Vectashield). To characterise 
the cultured OEC population, cell counts per 10x field 
were performed (n = 5). Total cell number per field was 
determined by DAPI nuclear staining and the percentage 
of p75 and fibronectin positive cells determined by count-
ing on Fiji ImageJ.44
LIVE/DEAD staining was performed by washing cell-
hydrogel construct with 37°C PBS followed by immersion 
for 1 h in 4µM calcein and 6µM ethidium homodimer at 
37°C. Confocal images were obtained immediately after 
staining using a Leica SP5-AOBS confocal laser scanning 
microscope attached to a Leica DM I6000 inverted epif-
luorescence microscope. For each gel, 3–4 image stacks 
through the depth of the gel were obtained from random 
areas and number of LIVE and DEAD stained cells quanti-
fied for each z-plane using a custom Fiji/ImageJ macro 
running thresholding and segmentation followed by parti-
cle analysis. The number of LIVE cells out of total LIVE 
and DEAD stained cells was expressed as a percentage (% 
LIVE) and averaged for each image stack and gel.
Mechanical indentation measurement of 
elasticity
To allow direct comparison of standard mechanical inden-
tation and USE measurements, both measures were per-
formed on ZerdineTM hydrogel samples of manufacturer 
certified stiffness. ZerdineTM is a proprietary polymer 
hydrogel based on polyacrylamide.45 Indentation testing 
was conducted using a Universal Testing Machine 3367 
(Instron) fitted with a 10 N load cell and 2 mm radius cylin-
drical indenter. Cylindrical ZerdineTM samples (radius 
3.4 mm and height 8 mm) were deformed at a rate of 
0.02 mm/s up to a maximum of 5 mm or 3 N of force. The 
best-fit line forming the gradient of the linear section of 
the resulting force-extension graph (0–10% strain) was 
used to obtain a value for stiffness in N/mm. This was con-
verted to Young’s modulus (Pa) using published methods46 
assuming that gels behave as a thin elastic layer on a rigid 
surface.43,47,48 Briefly, published finite element analysis 
defines the load–depth relationship for a given ratio of 









where P = load, E = Young’s modulus, ν = Poisson’s ratio, 
a = radius of indenter, h = indentation depth/extension, 
FEA = finite element analysis constant. By rearranging for 
E and substituting the described N/mm gradient for the 
term ‘P/h’, Young’s modulus can be calculated. The value 
for ‘FEA’ is based on gel and indenter size and in our 
set-up = 1.48.
USE
All USE was performed using a Siemens Acuson S2000 
(Siemens Healthcare, Erlangen, Germany) with ‘Virtual 
Touch Imaging Quantification’ Acoustic Radiation Force 
Impulse imaging software using a 9 L4 linear matrix array 
transducer operating at 8 MHz. The region of interest size 
with this probe was 5 mm x 5 mm. An error, depicted as 
‘x.xx’ m/s, is returned if the confidence level between 
tracking beams is below 80%.49 If ‘x.xx m/s’ was returned, 
the measurement was discounted and repeated.
Recorded shear wave velocities (m/s) were converted to 
Young’s modulus of elasticity (kPa) using previously pub-
lished methods.28,29 Briefly, shear wave velocity can be 
converted to shear modulus by G c= ρ 2  (where G = shear 
modulus, ρ = density of material, and c = shear wave 
velocity) and shear modulus can be converted to Young’s 
modulus by G = E / (2(1 + ν)) (where E = Young’s modu-
lus, ν = Poisson’s ratio). Young’s modulus was therefore 
calculated by E = (2(1 + ν)) ρc2 . Poisson’s ratio and den-
sity are material dependent, and values used are reported 
in the relevant sections below. Calculated values reported 
as modulus of elasticity are therefore taken to be the 
Young’s modulus.
Calibration of USE. An elastography phantom (Elasticity 
QA Phantom model 049A, Computerised Imaging Refer-
ence Systems, Norfolk, VA) was used to allow calibration 
of our USE measures. The phantom contains four stepped 
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diameter cylindrical ZerdineTM ‘targets’ of known stiffness 
(10, 14, 46 and 86 kPa) in background (27 kPa). Stiffnesses 
are certified by manufacturer’s mechanical testing. Ten 
measurements were taken from each of the four cylinders 
at a consistent point along their length (section of diameter 
16.7 mm, comparable to spinal cord). Measurements from 
background were taken at a consistent depth of 3 cm. The 
manufacturer reports ZerdineTM to have a density of 
1.04 ± 0.01 g/cm3 and a Poisson’s ratio of 0.5.50
USE of Zerdine. As described above, additional samples 
of ZerdineTM hydrogel at varying certified elasticities 
were used to provide a direct comparison between USE 
and mechanical indentation measures. For USE measures 
Zerdine cylinders 12 mm diameter and 10 mm long were 
submerged to a depth of 2 cm in PBS and 20 measures 
obtained from the centre of each sample.
USE of canine cadaver spinal cord. As initial proof-of-prin-
ciple that USE could be used on canine spinal cord, meas-
urements were performed on canine cadaveric specimens 
from clinical cases undergoing post-mortem examination 
at Bristol Veterinary School, having been euthanized at 
owners’ request for medical reasons unrelated to this study 
and for conditions not involving the spinal cord. Written 
owner consent was obtained and ethical approval gained 
from the University of Bristol local ethical review panel 
(VIN/16/004). Dogs were excluded if they had spinal cord 
pathology determined based on clinical signs or gross 
post-mortem examination.
The spinal cord was removed from the vertebral column 
within 6 h of euthanasia and placed in isotonic saline solu-
tion. The spinal cord was transversely sectioned to obtain the 
C1-T2, T3-L3 and L4-S4 spinal segments which were 
immobilised in plastic containers. The ultrasound transducer 
was positioned in contact with the saline and the cord viewed 
in sagittal section at a depth of 2 cm. The hyperechoic central 
canal was visualised along the length of the ultrasound win-
dow to ensure the probe was held parallel and repeat meas-
urements (n = 5) of shear wave velocity were taken from 5 
regions (cervical, cervical intumescence, thoracic, lumbar, 
lumbar intumescence) of each cadaver cord.
USE of intraoperative canine spinal cord. Dogs, 5–20 kg, 
undergoing spinal cord decompressive surgery following 
acute thoracolumbar intervertebral disc extrusion were 
recruited at Langford Vets (Bristol Veterinary School 
Small Animal Hospital). These dogs present with signs of 
transverse myelopathy such as back pain, pelvic limb 
ataxia, paresis, paralysis, incontinence and loss of pain 
sensation in the worst cases. Ethical approval (VIN/15/036) 
and informed verbal owner consent was obtained.
Anaesthesia was at the discretion of the attending veteri-
nary anaesthetist; consisting of pre-medication, intravenous 
induction, tracheal intubation and maintenance on inhala-
tional anaesthetic in oxygen, with appropriate clinical moni-
toring and analgesia throughout surgery and recovery. The 
spinal cord was exposed by hemilaminectomy or mini-
hemilaminectomy and the compressive disc material 
removed. The ultrasound probe was placed in contact with 
sterile saline at 37°C filling the surgical site as previously 
reported.51 Sterility was maintained by placing the ultra-
sound transducer in either a sterile glove or sterile sleeve 
(Safersonic Medizinprodukte, Austria) based on surgeon 
preference, with the cable in a sterile endoscope sleeve 
passed to an operator at the ultrasound machine. The spinal 
cord was initially visualised in B-mode ultrasound for orien-
tation in a sagittal plane, with orientation being confirmed 
by visualisation of the hyperechoic central canal between 
the hyperechoic dura. The region of interest box was posi-
tioned over the spinal cord at the lesion site (‘lesion epicen-
tre’) and as far cranial and caudal to it as possible within the 
surgical window (approximately 1–2 cm). Cranial and cau-
dal measures of shear wave velocity were combined in one 
data set (‘lesion periphery’). Three repeat measures were 
recorded at each location (lesion epicentre, cranial and cau-
dal) where the cord could be reliably visualised.
Poisson’s ratio can be assumed to be 0.5 for soft tis-
sue.29 The density of canine spinal cord is unknown but 
human spinal cord has been reported52 as 1.03 g/cm3, so 
this value was used for calculations as an approximation.
USE of hydrogels and hydrogel encapsulating OECs. Collagen 
hydrogels ± OECs, synthesised as above (n = 3–4 per con-
centration) were measured by USE within 2 h of cell 
encapsulation (day 0) then at 24 and 72 h. For measure-
ment, gels were moved with a spatula onto sterile 10% 
gelatin submerged in sterile 37°C PBS. Twenty measure-
ments were recorded from the centre of each gel at a depth 
of 2 cm at each time point before being moved back to 
fresh cell culture medium in 24-well plates. Measurements 
of shear wave velocity were converted to Young’s modulus 
as described above based on a Poisson’s ratio of 0.5 and 
density48 of 1 g/cm2.
Statistical analysis
Data were tested for normality using the Shapiro-Wilk test. 
Parametric data were analysed using means, t-test, linear 
regression and analyses of variance (ANOVAs) with post 
hoc Tukey tests. Unless otherwise stated error bars are stand-
ard deviation and statistical significance is displayed as 
* = p < 0.05, ** = p < 0.01, *** = p < 0.001. Non-parametric 
data were assessed with median, range, inter-quartile range, 
Mann–Whitney U, Kruskall-Wallis and Dunn’s post hoc 
tests. All statistical analysis was performed in either 
Graphpad Prism (v8.3.0, GraphPad Software, La Jolla 
California USA) or RStudio (v 1.1.463).53
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Results
USE calibration and validation
A strong, positive, linear correlation was seen between cer-
tified phantom elasticity values and USE measures 
(r = 0.996, R2 = 0.991, p = 0.0003) (Figure 1(a)). The equa-
tion of the line of linear regression (y = 0.663x, where ‘y’ is 
measured elastic modulus and ‘x’ is phantom elastic mod-
ulus) defines this relationship and allows calibration of the 
ultrasound measures in our set-up. All subsequent USE 
measures reported here are corrected by this calibration.
A comparison between USE and mechanical indenta-
tion elasticity measures of five samples of ZerdineTM 
(Figure 1(b)) across a range of elasticities from 8 to 80 kPa 
shows no significant difference between the two tech-
niques (two-way ANOVA).
USE measures of spinal cord
USE of cadaver canine spinal cord demonstrates applicability 
of the technique to spinal cord. Three dogs were used for 
investigation of cadaver cord. Their ages ranged from 5 to 
7 years; breeds included a Sprocker, Bull Mastiff cross and 
Flat Coat Retriever. Causes of death were haemolytic 
anaemia, left cerebral hemisphere glioma, and dilated car-
diomyopathy respectively.
Ultrasound images of the spinal cord were clear when 
scanning submerged in saline (Figure 2(a) and (b)). No 
significant difference was seen between regions of cadaver 
spinal cord (one-way ANOVA) (Figure 2(c)) and an over-
all average cadaver spinal cord modulus of elasticity was 
calculated as 11.6 ± 4.7 kPa.
Clinical intraoperative USE of canine spinal cord is feasi-
ble. Fifteen dogs with injury between T3 and L3 spinal 
cord segments were recruited. The transducer could be 
simply oriented towards the spinal cord in contact with 
saline filling the surgical approach to visualise the spinal 
cord (Figure 3(a)). In 2 dogs, the spinal cord could not be 
reliably visualised through a smaller mini-hemilaminec-
tomy approach. For the remaining 13 animals: 4 had mini-
hemilaminectomies and 9 had hemilaminectomies; ages 
ranged from 4 to 8 years; 9 animals were male and 4 
female; breeds included six Dachshunds, two Cocker 
Spaniels, one Beagle, Basset Hound, Labrador, Jack Rus-
sel Terrier and Cavalier King Charles Spaniel cross Pug. 
All animals were in the acute or sub-acute phase of injury,54 
at less than 2 weeks from first onset of clinical signs, with 
the majority in the acute phase. They showed clinical signs 
ranging from paraparesis (n=9) to paraplegia with loss of 
pain sensation in the pelvic limbs (n=4).
After visualisation of the spinal cord (Figure 3(b)), 
areas of compression could be readily identified by: (1) 
visualisation of hyperechoic disc material ventral to the 
spinal cord, (2) loss of visible hyperechoic central canal 
within spinal cord, (3) narrowing and/or irregularity of 
hyperechoic dura mater dorsal and/or ventral to the spinal 
cord, and (4) direct surgeon visualisation. Intraoperative 
USE was feasible, and measures of shear wave velocity 
could be obtained from the spinal cord. In three animal 
readings could not be obtained for all locations (lesion epi-
centre, cranial and caudal at the lesion periphery).
Variability of intraoperative USE measures was 
assessed by determining the coefficient of variation for 
peripheral and lesion epicentre measures for each dog 
(Figure 3(c)). The average coefficient of variation for 
Figure 1. Calibration and validation of ultrasound elastography. (a) Ultrasound elastography stiffness measures (n = 10) of certified 
ultrasound elasticity phantom values (stiffnesses: 10, 14, 27, 46, 86 kPa) are shown along with the line of linear regression. All 
further presented values for ultrasound elastography are calibrated using this conversion. (b) A comparison between ultrasound 
elastography and standard mechanical indentation measurements of elasticity was made on five different ZerdineTM hydrogel 
samples to validate ultrasound elastography measures. No significant difference was seen between measurement techniques across 
the range of samples (8–80 kPa; two-way ANOVA).
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peripheral and lesion epicentre spinal cord was similar at 
32.0% ± 12.1% and 31.0% ± 22.6% respectively. The 
median distance from transducer to spinal cord (i.e. meas-
urement depth) was 19.5 mm, with a range of 16–25 mm. 
No significant correlation was seen between depth and 
either peripheral or lesion epicentre stiffness measures 
across this relatively small range.
Stiffness of lesion epicentre is significantly lower than periph-
ery spinal cord. Intraoperative USE measures of the spinal 
cord at the lesion epicentre had a significantly lower mod-
ulus of elasticity than at the lesion periphery (p = 0.0056, 
Mann–Whitney U), with a median of 18.3 kPa (inter-quar-
tile range (IQR): 11.6–31.1 kPa) and 47.9 kPa (IQR: 32.6–
81.7 kPa) respectively (Figure 3(d)). It was noted that the 
only 2 dogs in this cohort whose modulus of elasticity was 
not lower at the lesion compared to peripheral spinal cord 
were the only dogs in this cohort who did not recover sen-
sation and motor function after injury (grey arrows mark 
these 2 cases in Figure 3(d)).
Comparison of intraoperative measures to earlier 
cadaver measures shows a significant difference between 
cadaver and intraoperative peripheral spinal cord stiffness 
(p = 0.0254, Kruskall Wallis followed by Dunn’s multiple 
comparison test). There is no significant difference between 
cadaver and intraoperative lesion epicentre measures.
Encapsulation of canine OECs in high 
concentration collagen hydrogel
USE of large, high collagen concentration hydrogels is feasi-
ble. Collagen hydrogels of diameter 11 mm (Figure 4(a)) 
could be reliably imaged by ultrasound when submerged 
in saline (Figure 4(b)). Measurements of stiffness by USE 
(Figure 4(c)) show a strong linear correlation between 
increasing collagen concentration and increasing stiffness 
(r = 1.0, R2 = 1.0, p < 0.0042; equation of line of linear 
regression y = 1.57x − 4.36).
OEC viability is not significantly affected by collagen concentra-
tion. Canine OEC culture populations were characterised 
by immunofluorescence cytochemistry before encapsula-
tion, with no contaminant fibroblasts seen (Figure 5(a)). 
Culture of OECs within large, high collagen concentration 
hydrogels was possible with normal bipolar, spindle 
shaped OEC morphology seen through the depth of hydro-
gel by immunofluorescence (Figure 5(b)). LIVE/DEAD 
staining (Figure 5(c)) showed no significant difference 
(two-way ANOVA) in proportion of live cells between col-
lagen concentrations (4.5–7.5 mg/ml). There was an over-
all significant effect of time (F(1, 15) = 10.2, p = 0.006; 
two-way ANOVA) but no significant difference within any 
collagen concentration in the proportion of live cells 
between day 1 and 3 (post hoc Tukey test). The overall 
average proportion of live cells was 91.1% ± 1.9% on day 
1 and 76.3% ± 7.3% on day 3 (Figure 5(d)).
Encapsulation of OECs increases collagen hydrogel stiffness. 
Within 2 h after encapsulation of OECs, the stiffness of all 
hydrogel constructs was increased compared to acellular 
hydrogels (fold increase in mean: 1.25 in 4.5 mg/ml, 1.57 in 
6 mg/ml, 1.73 in 7.5 mg/ml) (Figure 6(a)). This increase was 
significant in the 6 mg/ml and 7.5 mg/ml gels (F(1, 12) = 57, 
p < 0.0001 for encapsulation on two-way ANOVA, post hoc 
Tukey test p = 0.012 and p < 0.0001 respectively).
Stiffness of these cellular hydrogel constructs is also 
significantly increased with increasing collagen concentra-
tion (F(2, 12) = 106, p < 0.0001 for collagen concentration 
Figure 2. Ultrasound elastography stiffness measures of cadaver spinal cord. Ex vivo spinal cord samples from fresh canine 
cadavers were suspended in saline and the ultrasound probe held 3 cm away in contact with the saline to image in sagittal section 
(a, black arrow is spinal cord). The spinal cord was clearly visible on the resulting ultrasound images, with the hyperechoic central 
canal identifiable (b, white square shows 5mm x 5 mm region of interest for stiffness measurements). Ultrasound elastography 
measurements at 5 points along the length of the dissected spinal cord in 3 dogs (c) show no significant difference between regions 
(one-way ANOVA).
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on two-way ANOVA) with a linear correlation (r = 0.99, 
R2 = 0.98, p = 0.0060; equation of line of linear regression 
y = 3.14x − 10.8).
Over 3 days of culture, there is a significant effect 
of time on hydrogel construct stiffness when measured 
by USE (F(2, 24) = 12, p = 0.0002 repeated measures 
two-way ANOVA) (Figure 6(b)). The highest concentra-
tion 7.5 mg/ml collagen hydrogel encapsulating OECs 
significantly increases stiffness in the first 24 h of culture 
(p = 0.0087, post hoc Tukey test) and further increases 
stiffness to day 3 (p = 0.016 compared to day 1, p < 0.0001 
compared to day 0). Other cellular collagen concentra-
tions and acellular hydrogels do not change stiffness 
when kept in cell culture conditions (37°C, 5% CO2) for 
3 days (no significant difference between days, post hoc 
Tukey test).
Figure 3. Ultrasound elastography stiffness measures of in vivo intraoperative spinal cord. Intraoperative ultrasound elastography 
stiffness measures were performed by placing the ultrasound transducer within the surgical incision filled with saline (a, non-surgical/
non-sterile example of set-up). An example in vivo intraoperative ultrasound image of the spinal cord is shown in (b). The injury site 
can be identified with herniated disc visible (white arrow) and loss of hyperechoic central canal due to compression of the cord at 
this site. The coefficient of variation for lesion epicentre (black) and lesion periphery (grey) measures are graphed for each dog (c). 
Horizontal dotted lines show average coefficient of variation for lesion epicentre (black, 31.0%) and lesion periphery (grey, 32.0%). 
Missing columns reflect measures unable to be obtained. A significantly decreased modulus of elasticity (p = 0.0056, Mann-Whiney 
U, n = 13) is seen at the lesion compared to peripheral cord intraoperatively (d). Dots mark average measured values for each dog, 
grey lines denote comparison within same dog where this is possible (n = 10), grey arrows mark the only 2 dogs where modulus of 
elasticity is not lower at the lesion.
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Figure 4. Ultrasound elastography stiffness measurement of collagen hydrogels. Large, cylindrical (11 mm diameter, 0.5 ml volume) 
collagen hydrogels were synthesised (a) and measured by ultrasound elastography submerged in saline (b). A linear correlation was 
seen between increasing collagen concentration and increasing modulus of elasticity (c) (r = 1.0, R2 = 1.0, p < 0.0042).
Figure 5. OEC viability in large, high collagen concentration hydrogels. An example immunofluorescence image of canine OECs 
immunostained for p75 (red, OECs) and fibronectin (green, FN, fibroblasts, none seen) is shown before (a) and after encapsulation 
in hydrogel (b). Example confocal images are shown of encapsulated OECs LIVE (green) and DEAD (red) stained within 7.5 mg/ml 
collagen hydrogel at day 1 and 3 of culture (c). The proportion of live cells was determined (d) with no significant difference seen 
between collagen concentrations or time points (two-way ANOVA).
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Discussion
We report proof-of-concept of a clinically applicable, non-
invasive and USE based approach to stiffness-matching of 
implantable hydrogels for SCI repair. To our knowledge, 
this is the first report of such a stiffness-matching approach 
for biomaterial therapies in neurological injuries.
Both machine55 and transducer56 can affect USE meas-
ures, even within ARFI elastography. This highlights the 
necessity to standardise USE values against known meas-
ures to allow valid comparison between centres and 
machine set-ups. This is particularly vital in order to pro-
vide a useable reference measurement to the biomaterials 
community and those developing novel materials. The 
USE data presented here have therefore been calibrated to 
a commercially available elasticity phantom and certified 
elasticities of ZerdineTM, a proprietary, polyacrylamide-
based hydrogel commonly used in elastography quality 
assurance.28 Mechanical indentation is commonly used for 
elasticity testing in biomaterials testing and the close cor-
relation between our indentation and USE measures of 
ZerdineTM provide confidence in the accuracy and reliabil-
ity of our data.
Median intraoperative USE values for lesion epicentre 
(18.3 kPa), periphery (47.9 kPa) and values for cadaver 
canine spinal cord (11.6 kPa) determined here are within 
the range of values previously reported in the literature for 
spinal cord. A value of 18.5 ± 7 kPa was reported for unin-
jured in vivo cervical cord when measured by USE in 
experimental dogs, although these measures were not cali-
brated.26 The elasticity of spinal cord in anaesthetised 
experimental puppies and cats22,23 was reported as 265 kPa 
when measured using mechanical methods (tensile exten-
sion at loads of 5–10 g). As with our findings, this was 
higher than measures of canine cadaver spinal cord under 
the same conditions (11.9–16.8 kPa).1,20 Ex vivo measures 
of spinal cord give an even broader range of values, from 
1.3 kPa in rats57 (measured by indentation, maximum load 
25 µN) up to 1.4 MPa in humans58 (with high-strain tensile 
measurement up to 20% strain).
Due to the viscoelastic nature of spinal cord, the method 
of elasticity measurement and the precise testing parameters 
(e.g. strain of tensile measures59 or frequency of oscillatory 
rheology60) can affect the modulus of elasticity determined. 
Notably, higher strain increases the measured modulus of 
elasticity61,62 but changes in strain rate have been reported 
not to have an effect58 (for a review see Bartlett et al.,63). For 
example, bovine spinal cord white matter measured by ten-
sile measurement was reported to have a modulus of elastic-
ity of 1.05 MPa with a strain of 40% and 115 kPa with a 
strain of 5% in the same study.64 Reported measurements of 
spinal cord elasticity therefore need to be taken in the con-
text of measurement parameters.
Furthermore, reports of spinal cord elasticity are mainly 
from post-mortem tissue. Time post-mortem and degree of 
tissue degradation, storage conditions, temperature and 
hydration status are additional variables that can affect 
elasticity measurement and contribute to the wide range in 
Figure 6. Effect of olfactory ensheathing cell encapsulation on hydrogel stiffness. Stiffness of collagen hydrogels (4.5, 6 or 7.5 mg/
ml) was determined by ultrasound elastography before (open symbols) and immediately after (filled symbols) encapsulation of OECs 
(a). Encapsulation increased stiffness, reaching significance in 6 mg/ml and 7.5 mg/ml gels (two-way ANOVA, post hoc Tukey test; 
*p = 0.012, ****p < 0.0001). Continued culture to 3 days and repeated stiffness measurement (b) showed no change in stiffness of 
acellular gels over time (dotted lines), and an increased stiffness in gels encapsulating OECs at 7.5 mg/ml only (repeated measures 
two-way ANOVA, post hoc Tukey test; ††p = 0.0087 between day 0 and 1, †p = 0.016 between day 1 and 3 and p < 0.0001 between 
day 0 and 3).
10 Journal of Tissue Engineering 
reported values.65,66 Inclusion or exclusion of meninges in 
sample dissection is important; human cadaveric spinal 
cord has been reported to have an elastic modulus of 
1.4 MPa with intact pia mater and 89 kPa with cut pia 
mater in the same study with high strain (20%) tensile 
measurement.58
There are therefore a variety of experimental factors 
that make exact quantitative comparison between different 
measurement techniques and different studies extremely 
challenging. This has prevented simple comparison 
between spinal cord and biomaterial stiffness and is a 
major barrier to clinical hydrogel development and trans-
lation of experimental hydrogel therapies. Crucially, our 
approach utilises the same USE technique to measure both 
spinal cord and hydrogel. It avoids the problems inherent 
in comparing different elasticity measurement techniques 
and provides a direct comparison between in vivo tissue 
and in vitro hydrogel that is unreported for spinal cord.
When measured by USE, collagen hydrogels in this 
study (4.5–7.5 mg/ml collagen) have stiffnesses of the 
same order of magnitude as canine intraoperative injured 
spinal cord. For clinical transplant, we anticipate implant 
stiffness would be matched to the lowest stiffness in host 
tissue to avoid iatrogenic damage and ensure safe trans-
plantation. Matching hydrogel stiffness to an individual 
patient’s specific injury stiffness would be possible given 
the clear linear correlation we see between collagen con-
centration and modulus of elasticity.
OECs encapsulated within these stiffnesses of collagen 
hydrogel show high viability up to 3 days in culture, at an 
OEC concentration applicable to clinical transplants.33 
Clinical transplantation would likely occur within this 
3-day time-period, if not immediately after encapsulation 
(prior to gelation) if a percutaneous injectable approach 
were used. Previous work has also shown high OEC via-
bility after hydrogel encapsulation in lower concentration 
collagen hydrogels,39 Matrigel67 and polylactic-co-gly-
colic acid (PLGA)68 hydrogels, although not in alginate.67 
Collagen hydrogels were used in this study because of 
their prior use in experimental SCI repair,12,69 including for 
cell encapsulation,70,71 and because collagen is highly bio-
compatible;1 a variety of collagen products from various 
sources have been FDA approved for use in the nervous 
system,72 including as medical sealants for dural repair.73
We report an increase in overall stiffness of the hydro-
gel construct after OEC encapsulation, and so highlight an 
important consideration for stiffness-matching and hydro-
gel synthesis. There is considerable literature assessing the 
effect of hydrogel stiffness on cell fate,74–77 but less infor-
mation on the effect of cell encapsulation on construct 
stiffness. Fibroblast encapsulation in collagen hydrogels 
has been reported to increase stiffness,78 further increasing 
with continued culture.78,79 This increased stiffness could 
be due to extracellular matrix (ECM) deposition by the 
cells,78 protein adsorption to the collagen,80 or a direct bulk 
effect of the high density of cells. The increased stiffness 
with OEC encapsulation we observed was less marked 
than that reported with fibroblasts,78,79 which may be due 
to the different functions of the cell types encapsulated. 
Unlike OECs, one of the main roles of fibroblasts is to 
contract tissue.81 These findings emphasise the importance 
of testing hydrogel-cell constructs with a cell population 
that is clinically relevant to its intended use.
The stiffness changes in cell-hydrogel construct 
reported here have all been performed in vitro up to the 
point of transplant. However, the changes occurring in 
construct stiffness in vivo over time as host degradative 
enzymes and inflammatory cells interact with biodegrad-
able materials are largely unknown. The manner in which 
SCI stiffness itself changes over time is also poorly under-
stood; intraoperative USE measures could be used to 
investigate this further. These remain important areas for 
further study in tissue engineering.
These are the first in vivo SCI stiffness measures after 
natural injury, however, they corroborate experimental find-
ings in rats that injured spinal cord is less stiff than sur-
rounding spinal cord (previously measured using a custom 
microindentation system57 and atomic force microscopy82). 
There is a known interaction between stiffness of substrate 
and axon growth, with axons tending to grow better on lower 
stiffness substrates in vitro83–85 (for reviews see86,87). It has 
therefore been suggested that the lower stiffness seen in 
injured spinal cord in experimental models may be mechani-
cally more permissive for axon regeneration.57 Establishing 
that injured spinal cord tissue is also less stiff after natural 
injury in a large animal clinical model is therefore an impor-
tant extension of the experimental rodent work.
Improved understanding about changes to spinal cord 
stiffness after injury could also inform approaches to SCI 
repair.82 It would be particularly valuable to investigate the 
degree of axonal regeneration in vivo in response to stiff-
ness queues, for example, after implant of varying stiffness 
hydrogels into sites of SCI, to determine the most appro-
priate stiffness of implant to promote axon regeneration.
Our data also raise the important possibility that clinical 
severity and recovery may be related to SCI stiffness. A 
thorough investigation was beyond the scope of this study, 
but it is noteworthy that the two most severely affected 
animals (the only animals who did not recover walking by 
3 weeks after injury) had the highest stiffness at the SCI 
lesion and relative to surrounding cord. Using intraopera-
tive USE could therefore represent a tool to facilitate fur-
ther understanding of the relationship between clinical 
severity of injury and spinal cord mechanical properties, 
with correlation to recovery.
Conclusion
We have developed a protocol to non-invasively measure 
the in vivo stiffness of spinal cord after injury in a clinical 
setting, allowing us to provide a previously undetermined 
‘target’ value for clear specification and direction of 
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hydrogel synthesis. Our work addresses a knowledge gap 
in the development of hydrogels for clinical use. We pre-
dict our method could be directly used in veterinary medi-
cine in the context of trials testing implantation of an 
OEC-hydrogel construct for SCI repair. Importantly, 
reports of intraoperative spinal cord ultrasound in 
humans88,89 suggest these principles could be directly 
applied to human clinics.
The approach presented here is highly versatile and 
applicable to multiple hydrogel delivery systems for a wide 
range of applications (e.g. cell or drug/biomolecule hydro-
gel delivery in many target tissues). It provides the ability to 
rapidly and simply measure the stiffness of individual inju-
ries on clinics and match this to previously determined 
hydrogel construct stiffness. This may in the future allow 
bespoke hydrogel implants to be created for each patient at 
the time of transplant for ‘personalised cell therapy’.
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